BEUDAMED
    FDA Adverse Event Injury Summary report: N

    BACTIGRAS

    MDR report key: 16119585 · Received January 8, 2023

    Report

    Report Number
    8043484-2023-00004
    Event Type
    Injury
    Date Received
    January 8, 2023
    Date of Event
    May 28, 2009
    Report Date
    May 5, 2023
    Manufacturer
    SMITH & NEPHEW MEDICAL LTD.
    Product Code
    FRO
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    TU
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    INTERNAL COMPLAINT REFERENCE: (B)(4). DEMIRTAS, Y., YAGMUR, C., SOYLEMEZ, F., OZTURK, N., & DEMIR, A. (2010). MANAGEMENT OF SPLIT-THICKNESS SKIN GRAFT DONOR SITE: A PROSPECTIVE CLINICAL TRIAL FOR COMPARISON OF FIVE DIFFERENT DRESSING MATERIALS. BURNS, 36(7), 999-1005. DOI: 10.1016/J.BURNS.2009.05.017. THIS COMPLAINT WAS OPENED BY SMITH+NEPHEW TO DOCUMENT A PATIENT COMPLICATION IDENTIFIED THROUGH A REVIEW OF CLINICAL EVIDENCE FROM LITERATURE SOURCES THAT INCLUDES REFERENCE TO THE USE OF A SMITH+NEPHEW PRODUCT. THE REPORTED ISSUE(S) RELATE TO KNOWN INHERENT PROCEDURAL RISKS THAT ARE APPROPRIATELY DOCUMENTED IN OUR RISK FILES. SMITH+NEPHEW WILL CONTINUE TO MONITOR TRENDS IN ACCORDANCE WITH OUR POST-MARKET SURVEILLANCE PROCESS AND TAKE NECESSARY ACTION AS REQUIRED IF ANTICIPATED SEVERITY AND/OR OCCURRENCE RATES ARE EXCEEDED. SMITH+NEPHEW HAS NO REASON TO SUSPECT THAT THE PRODUCT FAILED TO MEET ANY SPECIFICATIONS AT THE TIME OF MANUFACTURE. BASED ON OUR REVIEW OF ALL CURRENTLY AVAILABLE INFORMATION, WE ARE UNABLE TO CONFIRM A RELATIONSHIP BETWEEN THE REPORTED EVENT AND THE DEVICE OR IDENTIFY A DEFINITIVE ROOT CAUSE. HOWEVER, AS THE USE OF OUR PRODUCT CANNOT BE EXCLUDED AS A POTENTIAL CAUSE OR CONTRIBUTORY FACTOR TO THE REPORTED ISSUE, WE ARE CONSERVATIVELY SUBMITTING THIS REPORT IN ACCORDANCE WITH APPLICABLE REGULATIONS. IF ADDITIONAL INFORMATION BECOMES AVAILABLE THAT ALTERS THE CONCLUSIONS OF THIS REPORT, A FOLLOW-UP REPORT WILL BE SUBMITTED AS REQUIRED.

    Description of Event or Problem · 0

    IT WAS REPORTED THAT ON LITERATURE REVIEW " MANAGEMENT OF SPLIT-THICKNESS SKIN GRAFT DONOR SITE: A PROSPECTIVE CLINICAL TRIAL FOR COMPARISON OF FIVE DIFFERENT DRESSING MATERIALS ", TWO (2) PATIENTS HAD AN UNSPECIFIED INSPECTION AFTER A RECONSTRUCTION WITH A SPLIT-THICKNESS SKIN GRAFT (STSG) USING BACTIGRAS WITH MELOLIN. IT IS UNKNOWN HOW THESE EVENTS WERE TREATED. THE PATIENTS' OUTCOME IS UNKNOWN. NO FURTHER INFORMATION IS AVAILABLE.

    Description of Event or Problem · 0

    IT WAS REPORTED THAT ON LITERATURE REVIEW " MANAGEMENT OF SPLIT-THICKNESS SKIN GRAFT DONOR SITE: A PROSPECTIVE CLINICAL TRIAL FOR COMPARISON OF FIVE DIFFERENT DRESSING MATERIALS ", THREE (3) PATIENTS HAD AN UNSPECIFIED INFECTION AFTER A RECONSTRUCTION WITH A SPLIT-THICKNESS SKIN GRAFT (STSG) USING BACTIGRAS WITH MELOLIN. IT IS UNKNOWN HOW THESE EVENTS WERE TREATED. THE PATIENTS' OUTCOME IS UNKNOWN. NO FURTHER INFORMATION IS AVAILABLE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1423963 BACTIGRAS DRESSING, WOUND, DRUG FRO SMITH & NEPHEW MEDICAL LTD. UNKNOWN

    Patients

    Seq Age Sex Outcome Treatment
    1 Unknown Other UNKNOWN MELOLIN.